Quantcast

Industry news that matters to you.  Learn more

QIAGEN Expands Clinical Decision Support for NGS in Oncology Labs

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced enhancements to its QIAGEN Clinical Insight® (QCI™) clinical decision support solution, which streamlines the annotation, interpretation and reporting of next-generation sequencing results (NGS) for clinical laboratories.

Maverix Biomics And Elsevier Sign Cooperation Agreement

Maverix Biomics, Inc. recently announced at the 23(rd) International Molecular Medicine Tri-Conference (Tricon) in San Francisco, CA that the company has signed a strategic cooperation agreement with Elsevier, a world-leading provider of scientific, technical and medical information products and services, to streamline the interpretation of raw next-generation sequencing (NGS) data to reveal new insights and to assist with critical decision making. The Maverix Analytic Platform will complement Pathway Studio’s sample-to-insight workflow and incorporation of biological data from Elsevier’s biology journals by providing easy, push-button data analysis, which is now integrated with Elsevier’s Pathway Studio research solution for biologists. Financial terms were not disclosed.

GenomOncology Collaborates With Vanderbilt-Ingram Cancer Center for the Commercial Development of My Cancer Genome Tools

GenomOncology and Vanderbilt-Ingram Cancer Center (VICC) recently announced a partnership for the exclusive commercial development of a decision support tool based on My Cancer Genome™, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers.